Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) Shares Outstanding (Diluted Average) (2017 - 2023)

Historic Shares Outstanding (Diluted Average) for Mesa Laboratories (MLAB) over the last 11 years, with Q4 2023 value amounting to $5.4 million.

  • Mesa Laboratories' Shares Outstanding (Diluted Average) rose 67.16% to $5.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.4 million, marking a year-over-year increase of 67.16%. This contributed to the annual value of $3.6 million for FY2015, which is 108.0% up from last year.
  • Latest data reveals that Mesa Laboratories reported Shares Outstanding (Diluted Average) of $5.4 million as of Q4 2023, which was up 67.16% from $5.4 million recorded in Q3 2023.
  • In the past 5 years, Mesa Laboratories' Shares Outstanding (Diluted Average) ranged from a high of $5.4 million in Q4 2023 and a low of $5.3 million during Q4 2021
  • Over the past 3 years, Mesa Laboratories' median Shares Outstanding (Diluted Average) value was $5.4 million (recorded in 2022), while the average stood at $5.4 million.
  • In the last 5 years, Mesa Laboratories' Shares Outstanding (Diluted Average) skyrocketed by 37.43% in 2022 and then soared by 67.16% in 2023.
  • Quarter analysis of 3 years shows Mesa Laboratories' Shares Outstanding (Diluted Average) stood at $5.3 million in 2021, then rose by 0.51% to $5.4 million in 2022, then increased by 0.67% to $5.4 million in 2023.
  • Its Shares Outstanding (Diluted Average) was $5.4 million in Q4 2023, compared to $5.4 million in Q3 2023 and $5.4 million in Q4 2022.